Johnson Pharmacare Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Net Income	-5.84	-1.96	-12.91	0.97	0.01	Upgrade
Other Operating Activities	-	-	-0	-0	0	Upgrade
Change in Accounts Receivable	-	-	10.5	6.3	-7.6	Upgrade
Change in Accounts Payable	-	-	-	-6.5	6.5	Upgrade
Change in Other Net Operating Assets	-13.25	1.51	-1.59	48.2	-	Upgrade
Operating Cash Flow	-19.09	-0.45	-4.01	48.97	-1.08	Upgrade
Investment in Securities	32.67	-	86.21	-	-	Upgrade
Investing Cash Flow	32.67	-	-9.38	-	-	Upgrade
Short-Term Debt Issued	-	0.45	13	-	0.62	Upgrade
Total Debt Issued	-	0.45	13	-	0.62	Upgrade
Short-Term Debt Repaid	-	-	-	-0.83	-	Upgrade
Long-Term Debt Repaid	-13.45	-	-	-	-	Upgrade
Total Debt Repaid	-13.45	-	-	-0.83	-	Upgrade
Net Debt Issued (Repaid)	-13.45	0.45	13	-0.83	0.62	Upgrade
Financing Cash Flow	-13.45	0.45	13	-0.83	0.62	Upgrade
Miscellaneous Cash Flow Adjustments	0	-	-	-50.06	-	Upgrade
Net Cash Flow	0.13	-0	-0.39	-1.92	-0.46	Upgrade
Cash Income Tax Paid	-	-	-0.38	0.38	-0	Upgrade
Levered Free Cash Flow	-158.53	0.28	10.37	48.91	-1.09	Upgrade
Unlevered Free Cash Flow	-158.53	0.28	10.37	48.91	-1.09	Upgrade
Change in Net Working Capital	155.95	-1.51	-8.91	-48	1.1	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.